Capital Square
ABBV icon

Capital Square’s AbbVie ABBV Stock Holding History

Capital Square’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$279K Buy
1,066
+10
+0.9% +$2.56K 0.12% 169
2026
Q2 		$262K Buy
1,056
+17
+2% +$3.66K 0.12% 190
2026
Q1 		$207K Sell
1,039
-9
-0.9% -$2K 0.1% 211
2025
Q4 		$239K Sell
1,048
-257
-20% -$58.5K 0.12% 180
2025
Q3 		$302K Sell
1,305
-12
-0.9% -$2.44K 0.15% 143
2025
Q2 		$254K Sell
1,317
-109
-8% -$20.3K 0.14% 165
2025
Q1 		$299K Sell
1,426
-34
-2% -$6.61K 0.18% 128
2024
Q4 		$249K Buy
1,460
+273
+23% +$50.2K 0.14% 149
2024
Q3 		$235K Buy
+1,187
New +$222K 0.14% 134
2023
Q1 		– Sell
-1,295
Closed -$209K – 145
2022
Q4 		$209K Buy
+1,295
New +$199K 0.19% 124
2022
Q3 		– Sell
-1,391
Closed -$213K – 133
2022
Q2 		$213K Sell
1,391
-11
-0.8% -$1.68K 0.18% 120
2022
Q1 		$227K Buy
+1,402
New +$204K 0.16% 133
2021
Q3 		– Sell
-3,695
Closed -$432K – 156
2021
Q2 		$432K Buy
3,695
+223
+6% +$25.1K 0.32% 92
2021
Q1 		$373K Sell
3,472
-97
-3% -$10.4K 0.28% 103
2020
Q4 		$382K Buy
3,569
+27
+0.8% +$2.6K 0.32% 96
2020
Q3 		$310K Buy
3,542
+3
+0.1% +$282 0.32% 96
2020
Q2 		$347K Sell
3,539
-346
-9% -$30.5K 0.37% 89
2020
Q1 		$296K Sell
3,885
-1,297
-25% -$110K 0.35% 83
2019
Q4 		$458K Buy
+5,182
New +$430K 0.44% 72

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Capital Square's ABBV Position: Q3 2026 in Review

Capital Square increased its AbbVie (ABBV) stake by 0.95% in Q3 2026, buying an estimated $2.56K and bringing the position to 1,066 shares worth $279K. The position accounts for 0.12% of the portfolio, ranked #169.

Capital Square first reported a position in ABBV in Q4 2019 and has held it in 19 quarters since. The position peaked at $458K in Q4 2019. 1,731 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Capital Square held 1,066 shares of AbbVie worth $279K as of Q3 2026.
  • Capital Square bought 10 AbbVie shares in Q3 2026, an estimated $2.56K.
  • AbbVie made up 0.12% of Capital Square's portfolio in Q3 2026, its #169 holding.
  • Capital Square first reported a position in AbbVie in Q4 2019 and has held it in 19 quarters since.
  • Capital Square's AbbVie position peaked at $458K in Q4 2019.
  • 1,731 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Capital Square's 13F filing for Q3 2026, filed 19 Oct 2026.